Teva, Allergan Finalize Multibillion-Dollar Global Opioid Deals

By Emily Field (November 22, 2022, 9:25 AM EST) -- Teva on Tuesday said that it had finalized a global deal worth up to $4.25 billion to end allegations brought by states and local governments that it fueled the opioid crisis by downplaying the risks of addiction, in addition to Allergan saying it finalized its own deal worth up to $2.02 billion....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!